FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1585561000168107: Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride 160 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL) gel, 4 mL vial (trade product unit of use)

Status: current, Defined. Date: 31-Dec 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4650721000168112 Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride 160 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL) gel, 4 mL vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4650731000168110 Laceraine Topical Wound Anaesthetic gel, 4 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a Laceraine Topical Wound Anaesthetic true Inferred relationship Some
Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial true Inferred relationship Some
Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a trade product unit of use true Inferred relationship Some
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has manufactured dose form gel true Inferred relationship Some
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS adrenaline (epinephrine) acid tartrate true Inferred relationship Some 1731826238
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient adrenaline (epinephrine) true Inferred relationship Some 1731826238
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient tetracaine (amethocaine) true Inferred relationship Some 77758040
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS tetracaine hydrochloride (AU substance) true Inferred relationship Some 77758040
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has unit of use vial true Inferred relationship Some 1808410413
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient lidocaine true Inferred relationship Some 1173489681
Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS lidocaine hydrochloride true Inferred relationship Some 1173489681
Inbound Relationships Type Active Source Characteristic Refinability Group
Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials has TPUU True Laceraine Topical Wound Anaesthetic gel, 4 mL vial Inferred relationship Some 1062129751
Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials has TPUU True Laceraine Topical Wound Anaesthetic gel, 4 mL vial Inferred relationship Some 652891371

Reference Sets

Trade product unit of use reference set

Back to Start